Journal
COMPUTATIONAL AND STRUCTURAL BIOTECHNOLOGY JOURNAL
Volume 20, Issue -, Pages 322-332Publisher
ELSEVIER
DOI: 10.1016/j.csbj.2021.12.016
Keywords
Long non-coding RNA; Functional prediction; Disease-associated SNPs; Coefficient of variation; WGCNA
Funding
- National Key Research and Development Program of China [2018YFC1004400]
- Natural Science Foundation of Chongqing [cstc2018jcyjAX0309]
- Outstanding Graduate Student Cultivation Program of Chongqing Medical University [BJRC201917]
Ask authors/readers for more resources
This study developed a novel strategy (DAnet) that combines disease associations with the cis-regulatory network between lncRNAs and neighboring protein-coding genes for functional annotation of lncRNAs. Compared to the traditional differential expression-based approach, DAnet performs better in identifying experimentally validated lncRNAs, and the identified biological pathways are associated with diseases.
The long non-coding RNAs (lncRNAs) play critical roles in various biological processes and are associated with many diseases. Functional annotation of lncRNAs in diseases attracts great attention in understanding their etiology. However, the traditional co-expression-based analysis usually produces a significant number of false positive function assignments. It is thus crucial to develop a new approach to obtain lower false discovery rate for functional annotation of lncRNAs. Here, a novel strategy termed DAnet which combining disease associations with cis-regulatory network between lncRNAs and neighboring protein-coding genes was developed, and the performance of DAnet was systematically compared with that of the traditional differential expression-based approach. Based on a gold standard analysis of the experimentally validated lncRNAs, the proposed strategy was found to perform better in identifying the experimentally validated lncRNAs compared with the other method. Moreover, the majority of biological pathways (40%similar to 100%) identified by DAnet were reported to be associated with the studied diseases. In sum, the DAnet is expected to be used to identify the function of specific lncRNAs in a particular disease or multiple diseases. (C) 2021 The Author(s). Published by Elsevier B.V. on behalf of Research Network of Computational and Structural Biotechnology.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available